Post Profile

Theranos: In Healthcare Most Good Ideas Don't Work

"In tech investors bet on people. Healthcare is different. In healthcare most great ideas don't work." Quoting myself seems a little odd, but that's where I landed yesterday after looking back on my two on-stage interviews with Theranos founder and chief executive Elizabeth Holmes. The main point of this post is [...]
read more


Related Posts

Blood-testing 'vampires' want to take down Theranos, says investor Tim Draper

Technology / Technology Industry News : Silicon Alley Insider

Troubled blood-testing startup Theranos still has one big, vocal fan: the guy that invested the seed money to get the company started, famed investor Tim Draper. Draper tells Business Insider that of all the startups out there, Ther...

10 things in tech you need to know today (GOOG, AAPL, YHOO)

Technology / Technology Industry News : Silicon Alley Insider

Good morning! Here's the tech news you need to know this Tuesday. 1. Beleaguered healthcare startup Theranos is now facing a criminal investigation. It hinges on whether it misled investors about its technology. 2. Silicon Valley le...

Early stage startups don’t need a perfect idea, they need a great thesis

Business & Finance / Venture Capital : The Equity Kicker

Investors are frequently asked what they look for in a good startup and most good ones answer “Great team, great product and great market”. With early stage companies team is paramount because that’s just about all there is in the c...

The Fallout From Valeant And Theranos Threatens The Healthcare And Biotech Rally

Business & Finance : Forbes: Business

Valeant Pharmaceuticals and Theranos serve different segments of the healthcare sector. Valeant is a publicly traded company that develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices ar...

Silicon Valley Looks for Lessons in Theranos

Technology : Tech -

Silicon Valley’s best-known venture investors have emerged largely unscathed from the rapid descent of Theranos, but the decline offers a cautionary tale for a community that bets big on visionary founders touting revolutionary tech...


Copyright © 2016 Regator, LLC